Lipigon Pharmaceuticals AB Financial Flexibility Index
Lipigon Pharmaceuticals AB financial flexibility index. Lipigon Pharmaceuticals AB (LPGO) has a Financial Flexibility Index of -1.79x as of December 2025. Free cash flow of Skr-6.38 Million (operating CF Skr-6.38 Million minus capex Skr0.00) represents -2% of total liabilities (Skr3.57 Million). See how much free cash does Lipigon Pharmaceuticals AB generate to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Lipigon Pharmaceuticals AB (2018–2025)
Financial flexibility index of Lipigon Pharmaceuticals AB from 2018 to 2025. Historical Financial Flexibility Index trend for Lipigon Pharmaceuticals AB across 8 annual periods. Check Lipigon Pharmaceuticals AB (LPGO) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Lipigon Pharmaceuticals AB Financial Flexibility Index by Year (2018–2025)
Lipigon Pharmaceuticals AB financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Lipigon Pharmaceuticals AB. For the full cash flow conversion analysis, see cash flow conversion of Lipigon Pharmaceuticals AB.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -9.98x | Skr-35.66 Million | Skr-35.77 Million | Skr3.57 Million | ▼ -187.2% |
| 2024 | -3.48x | Skr-24.55 Million | Skr-24.78 Million | Skr7.06 Million | ▼ -25.2% |
| 2023 | -2.78x | Skr-14.32 Million | Skr-14.32 Million | Skr5.16 Million | ▲ +48.5% |
| 2022 | -5.39x | Skr-37.47 Million | Skr-37.47 Million | Skr6.95 Million | ▲ +0.8% |
| 2021 | -5.44x | Skr-35.18 Million | Skr-35.30 Million | Skr6.47 Million | ▼ -44.5% |
| 2020 | -3.77x | Skr-8.51 Million | Skr-8.62 Million | Skr2.26 Million | ▲ +27.9% |
| 2019 | -5.23x | Skr-5.44 Million | Skr-5.56 Million | Skr1.04 Million | ▼ -77.3% |
| 2018 | -2.95x | Skr-3.14 Million | Skr-3.26 Million | Skr1.07 Million | — |